Evidence map›Paper›PMID 26277195›Full record

ArticleThe Journal of emergency medicine2015

The α- and β-Adrenergic Antagonist Controversy with Sympathomimetic Agents.

Matthew L Banks, Travis J Worst, Daniel E Rusyniak, Jon E Sprague

Abstract readLetterComment
In one paragraph

Article in The Journal of emergency medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Matthew L BanksDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia.
Travis J WorstOhio Attorney General's Bureau of Criminal Investigation, London, Ohio.
Daniel E RusyniakDepartments of Emergency Medicine and Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana.
Jon E SpragueThe Ohio Attorney General's Center for the Future of Forensic Science, Bowling Green State University, Bowling Green, Ohio.

Funding

Synthetic cathinones: a new class of illicit drugs affecting DAT & SERTR01DA033930 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI ELTIT, JOSE MIGUEL, GLENNON, RICHARD A · 2012 to 2016
$2.7M
NIDA NIH HHS R01 DA033930
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Substance-Related DisordersAlkaloidsCentral Nervous System StimulantsDesigner DrugsHumansPsychotropic DrugsAlkaloidsCentral Nervous System StimulantsDesigner DrugsPsychotropic Drugs

Identifiers

PMID26277195
PMCPMC5786445

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.